NIEHS/FDA CLARITY-BPA research program update

Jerrold J. Heindel, Retha R. Newbold, John R. Bucher, Luísa Camacho, K. Barry Delclos, Sherry M. Lewis, Michelle Vanlandingham, Mona I. Churchwell, Nathan C. Twaddle, Michelle McLellen, Mani Chidambaram, Matthew Bryant, Kellie Woodling, Gonçalo Gamboa da Costa, Sherry A. Ferguson, Jodi A Flaws, Paul C. Howard, Nigel J. Walker, R. Thomas Zoeller, Jennifer FostelCarolyn Favaro, Thaddeus T. Schug

Research output: Contribution to journalReview article

Abstract

Bisphenol A (BPA) is a chemical used in the production of numerous consumer products resulting in potential daily human exposure to this chemical. The FDA previously evaluated the body of BPA toxicology data and determined that BPA is safe at current exposure levels. Although consistent with the assessment of some other regulatory agencies around the world, this determination of BPA safety continues to be debated in scientific and popular publications, resulting in conflicting messages to the public. Thus, the National Toxicology Program (NTP), National Institute of Environmental Health Sciences (NIEHS), and U.S. Food and Drug Administration (FDA) developed a consortium-based research program to link more effectively a variety of hypothesis-based research investigations and guideline-compliant safety testing with BPA. This collaboration is known as the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA). This paper provides a detailed description of the conduct of the study and a midterm update on progress of the CLARITY-BPA research program.

Original languageEnglish (US)
Pages (from-to)33-44
Number of pages12
JournalReproductive Toxicology
Volume58
DOIs
StatePublished - Dec 1 2015

Fingerprint

National Institute of Environmental Health Sciences (U.S.)
United States Food and Drug Administration
Health
Research
Toxicology
Safety testing
Safety
Consumer products
bisphenol A
Toxicity
Publications
Guidelines

Keywords

  • Bisphenol A
  • CLARITY-BPA
  • Consortium
  • Endocrine disruptors
  • FDA
  • NIEHS
  • NTP

ASJC Scopus subject areas

  • Toxicology

Cite this

Heindel, J. J., Newbold, R. R., Bucher, J. R., Camacho, L., Delclos, K. B., Lewis, S. M., ... Schug, T. T. (2015). NIEHS/FDA CLARITY-BPA research program update. Reproductive Toxicology, 58, 33-44. https://doi.org/10.1016/j.reprotox.2015.07.075

NIEHS/FDA CLARITY-BPA research program update. / Heindel, Jerrold J.; Newbold, Retha R.; Bucher, John R.; Camacho, Luísa; Delclos, K. Barry; Lewis, Sherry M.; Vanlandingham, Michelle; Churchwell, Mona I.; Twaddle, Nathan C.; McLellen, Michelle; Chidambaram, Mani; Bryant, Matthew; Woodling, Kellie; Costa, Gonçalo Gamboa da; Ferguson, Sherry A.; Flaws, Jodi A; Howard, Paul C.; Walker, Nigel J.; Zoeller, R. Thomas; Fostel, Jennifer; Favaro, Carolyn; Schug, Thaddeus T.

In: Reproductive Toxicology, Vol. 58, 01.12.2015, p. 33-44.

Research output: Contribution to journalReview article

Heindel, JJ, Newbold, RR, Bucher, JR, Camacho, L, Delclos, KB, Lewis, SM, Vanlandingham, M, Churchwell, MI, Twaddle, NC, McLellen, M, Chidambaram, M, Bryant, M, Woodling, K, Costa, GGD, Ferguson, SA, Flaws, JA, Howard, PC, Walker, NJ, Zoeller, RT, Fostel, J, Favaro, C & Schug, TT 2015, 'NIEHS/FDA CLARITY-BPA research program update', Reproductive Toxicology, vol. 58, pp. 33-44. https://doi.org/10.1016/j.reprotox.2015.07.075
Heindel JJ, Newbold RR, Bucher JR, Camacho L, Delclos KB, Lewis SM et al. NIEHS/FDA CLARITY-BPA research program update. Reproductive Toxicology. 2015 Dec 1;58:33-44. https://doi.org/10.1016/j.reprotox.2015.07.075
Heindel, Jerrold J. ; Newbold, Retha R. ; Bucher, John R. ; Camacho, Luísa ; Delclos, K. Barry ; Lewis, Sherry M. ; Vanlandingham, Michelle ; Churchwell, Mona I. ; Twaddle, Nathan C. ; McLellen, Michelle ; Chidambaram, Mani ; Bryant, Matthew ; Woodling, Kellie ; Costa, Gonçalo Gamboa da ; Ferguson, Sherry A. ; Flaws, Jodi A ; Howard, Paul C. ; Walker, Nigel J. ; Zoeller, R. Thomas ; Fostel, Jennifer ; Favaro, Carolyn ; Schug, Thaddeus T. / NIEHS/FDA CLARITY-BPA research program update. In: Reproductive Toxicology. 2015 ; Vol. 58. pp. 33-44.
@article{1b8b84ed9bf748489e68954510b593a9,
title = "NIEHS/FDA CLARITY-BPA research program update",
abstract = "Bisphenol A (BPA) is a chemical used in the production of numerous consumer products resulting in potential daily human exposure to this chemical. The FDA previously evaluated the body of BPA toxicology data and determined that BPA is safe at current exposure levels. Although consistent with the assessment of some other regulatory agencies around the world, this determination of BPA safety continues to be debated in scientific and popular publications, resulting in conflicting messages to the public. Thus, the National Toxicology Program (NTP), National Institute of Environmental Health Sciences (NIEHS), and U.S. Food and Drug Administration (FDA) developed a consortium-based research program to link more effectively a variety of hypothesis-based research investigations and guideline-compliant safety testing with BPA. This collaboration is known as the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA). This paper provides a detailed description of the conduct of the study and a midterm update on progress of the CLARITY-BPA research program.",
keywords = "Bisphenol A, CLARITY-BPA, Consortium, Endocrine disruptors, FDA, NIEHS, NTP",
author = "Heindel, {Jerrold J.} and Newbold, {Retha R.} and Bucher, {John R.} and Lu{\'i}sa Camacho and Delclos, {K. Barry} and Lewis, {Sherry M.} and Michelle Vanlandingham and Churchwell, {Mona I.} and Twaddle, {Nathan C.} and Michelle McLellen and Mani Chidambaram and Matthew Bryant and Kellie Woodling and Costa, {Gon{\cc}alo Gamboa da} and Ferguson, {Sherry A.} and Flaws, {Jodi A} and Howard, {Paul C.} and Walker, {Nigel J.} and Zoeller, {R. Thomas} and Jennifer Fostel and Carolyn Favaro and Schug, {Thaddeus T.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.reprotox.2015.07.075",
language = "English (US)",
volume = "58",
pages = "33--44",
journal = "Reproductigve Toxicoloy",
issn = "0890-6238",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - NIEHS/FDA CLARITY-BPA research program update

AU - Heindel, Jerrold J.

AU - Newbold, Retha R.

AU - Bucher, John R.

AU - Camacho, Luísa

AU - Delclos, K. Barry

AU - Lewis, Sherry M.

AU - Vanlandingham, Michelle

AU - Churchwell, Mona I.

AU - Twaddle, Nathan C.

AU - McLellen, Michelle

AU - Chidambaram, Mani

AU - Bryant, Matthew

AU - Woodling, Kellie

AU - Costa, Gonçalo Gamboa da

AU - Ferguson, Sherry A.

AU - Flaws, Jodi A

AU - Howard, Paul C.

AU - Walker, Nigel J.

AU - Zoeller, R. Thomas

AU - Fostel, Jennifer

AU - Favaro, Carolyn

AU - Schug, Thaddeus T.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Bisphenol A (BPA) is a chemical used in the production of numerous consumer products resulting in potential daily human exposure to this chemical. The FDA previously evaluated the body of BPA toxicology data and determined that BPA is safe at current exposure levels. Although consistent with the assessment of some other regulatory agencies around the world, this determination of BPA safety continues to be debated in scientific and popular publications, resulting in conflicting messages to the public. Thus, the National Toxicology Program (NTP), National Institute of Environmental Health Sciences (NIEHS), and U.S. Food and Drug Administration (FDA) developed a consortium-based research program to link more effectively a variety of hypothesis-based research investigations and guideline-compliant safety testing with BPA. This collaboration is known as the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA). This paper provides a detailed description of the conduct of the study and a midterm update on progress of the CLARITY-BPA research program.

AB - Bisphenol A (BPA) is a chemical used in the production of numerous consumer products resulting in potential daily human exposure to this chemical. The FDA previously evaluated the body of BPA toxicology data and determined that BPA is safe at current exposure levels. Although consistent with the assessment of some other regulatory agencies around the world, this determination of BPA safety continues to be debated in scientific and popular publications, resulting in conflicting messages to the public. Thus, the National Toxicology Program (NTP), National Institute of Environmental Health Sciences (NIEHS), and U.S. Food and Drug Administration (FDA) developed a consortium-based research program to link more effectively a variety of hypothesis-based research investigations and guideline-compliant safety testing with BPA. This collaboration is known as the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA). This paper provides a detailed description of the conduct of the study and a midterm update on progress of the CLARITY-BPA research program.

KW - Bisphenol A

KW - CLARITY-BPA

KW - Consortium

KW - Endocrine disruptors

KW - FDA

KW - NIEHS

KW - NTP

UR - http://www.scopus.com/inward/record.url?scp=84939812084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939812084&partnerID=8YFLogxK

U2 - 10.1016/j.reprotox.2015.07.075

DO - 10.1016/j.reprotox.2015.07.075

M3 - Review article

C2 - 26232693

AN - SCOPUS:84939812084

VL - 58

SP - 33

EP - 44

JO - Reproductigve Toxicoloy

JF - Reproductigve Toxicoloy

SN - 0890-6238

ER -